‘Are you missing fraud?’: Joyce relentlessly grills California Medicaid Chief over crackdown process

Key Concepts

• Categorical Risk Level Classification: A tool used by Medicaid agencies to assess the risk of fraud, which dictates the level of oversight applied to providers (Limited, Moderate, or High).
• Home and Community-Based Services (HCBS): Programs designed to allow individuals to receive care in their homes rather than in institutional settings (e.g., nursing facilities).
• Provider Risk Profilers: Analytical tools used to identify high-risk areas (e.g., hospice, dental) beyond standard categorical classifications.
• Payment Deferral: A process where federal funding to states is withheld pending reconciliation or investigation of claims.
• Consumer-Directed Personal Assistance Program (CDPAP): A self-directed care model that allows patients to hire their own caregivers, which presents unique oversight challenges.

---

1. Medicaid Provider Risk Classification and Oversight

The hearing focused on the practice of classifying all "Medicaid-only" providers as "Limited Risk."

• The Controversy: Committee members challenged the "one-brush" approach, arguing that classifying all providers as limited risk results in less stringent oversight and potentially misses fraudulent activity.
• State Defense: Representatives from California stated that categorical risk is only one of many tools. They noted that for specific programs like In-Home Supportive Services (IHSS), the state employs additional safeguards, such as mandatory fingerprinting and criminal background checks, which are typically associated with higher-risk designations.
• Lack of Differentiation: It was revealed that, to the knowledge of the testifying officials, no Medicaid-only provider types in California have been classified as "Moderate" or "High" risk, despite the state’s claim of going "above and beyond" federal requirements.

2. Hospice and Home Health Licensure

A significant portion of the discussion addressed the regulatory environment for hospice care in California.

• Licensure Moratorium: The California Department of Public Health implemented a licensure moratorium in 2021 and recently introduced new, stricter regulations for hospice providers.
• Regulatory Gaps: The committee pressed for clarification on whether hospice organizations could operate without a state license prior to the recent regulatory updates. The witness declined to confirm the specific legal status of pre-moratorium operations, citing a lack of expertise on that specific regulatory history.

3. Data Accuracy and CMS Oversight

The hearing highlighted a sharp partisan divide regarding the Centers for Medicare & Medicaid Services (CMS) and its recent actions toward New York and California.

• The New York Data Dispute: Representative Clark highlighted a significant discrepancy in CMS data regarding New York’s Medicaid program. CMS claimed that nearly 75% of Medicaid beneficiaries received personal care services (approx. 4 million people). The actual figure, confirmed by the witness, was approximately 450,000 (less than 5%).
• Use of AI in Federal Oversight: It was revealed that a CMS footnote in a letter to New York cited ChatGPT as a source for analyzing its own data, which the committee characterized as an "embarrassment" and evidence of a lack of rigorous internal review.

4. Financial Deferrals and Program Integrity

The committee discussed the impact of CMS withholding $1.34 billion in federal funding from California.

• State Perspective: California officials argued that the deferral is "unprecedented" and punitive. They noted that the state had proactively disclosed concerns to CMS to ensure appropriate claiming.
• Impact on Services: The state emphasized that the growth in HCBS spending is a result of intentional policy choices to keep vulnerable populations out of expensive nursing facilities—a strategy they claim saves taxpayers approximately $100,000 per patient per year compared to institutional care.
• Lack of Evidence: The state asserted that CMS has not provided specific instances of "fraud, waste, or abuse" to justify the $1.1 billion deferral related to IHSS.

5. Synthesis and Conclusion

The hearing underscored a fundamental tension between federal oversight and state-led Medicaid administration. While the committee expressed deep concern regarding the potential for fraud in self-directed and home-based care programs, state officials defended their oversight frameworks as cost-effective and patient-centered. The session concluded with a call for more precise, data-driven oversight from CMS, following the revelation of significant mathematical errors in federal reports, while simultaneously highlighting the ongoing struggle to balance program integrity with the accessibility of essential home-based services.